Policies
Below are UNMC policies relating to biosafety (click policy number to view in PDF format):
- IBC-01: Autoclave Operation and Safety
- IBC-02: Biological Safety Cabinet Certification
- IBC-03: Biological Safety Cabinet Operation
- IBC-04: Biological Spill Clean-Up
- IBC-05: Biohazardous Waste Disposal
- IBC-06: Biosafety Training Program
- IBC-07: Centrifuge Safe Operation
- IBC-08: IBC Application & Review
Process forProcess: New Protocols (General) - IBC-09: IBC Application & Review
Process forProcess: New Protocols Utilizing Select Agents - IBC-10: IBC Application & Review
Process forProcess: New Protocols Involving Human Gene Transfer - IBC-11: IBC Laboratory Inspection Process
- IBC-12: IBC Review Process for Previously Approved Protocols
- IBC-13: Immunization Policy for Research Using Vaccinia Virus
- IBC-14: Paraformaldehyde Room and Biological Safety Cabinet Decontamination
- IBC-17: Laboratory Decommissioning
- IBC-19: Laboratory Commissioning, BL-2
- IBC-20: Laboratory Commissioning, BL-3
- IBC-24: Reporting Adverse Event
- IBC-29: Personnel Access for BL-3 Containment
- IBC-30: Category A High Consequence Pathogens
- IBC-32: Federal Permits for Shipment of Human Pathogens
- IBC-33: Off-site Laboratories
- IBC-34: Biosafety Risk Factor Assessment Process to Determine Appropriate Containment
- IBC-35: Registration Process for the Use of Exempt Recombinant DNA
- IBC-36: Visiting Scientist and Student for Access
- IBC-37: Serum Banking
- IBC-38: Personal Protective Equipment
- IBC-39: Pest Management
- IBC-40: Removal of Materials from the ABSL-3 or BSL-3 Laboratory
- IBC-41: Safe Handling and Disposal of Sharps
- IBC-42: Dual Use Research of Concern (DURC) Oversight
- IBC-43: Use of Human and Nonhuman Primate Tissues, Cells, and Cell Lines
- IBC-44: Allegations of Noncompliance